Were There Any Significant Reasons Why The TransCode Therapeutics (RNAZ) Stock Increased 38% Pre-Hours?
Following the release of clinical study data, TransCode Therapeutics Inc. (NASDAQ: RNAZ) soared 38.53% to $1.51 in pre-market trading hours on the most recent check Wednesday. What information did RNAZ share? Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Pancreatic Adenocarcinoma were released today by TransCode Therapeutics (RNAZ). In a mouse model of pancreatic […]